tak 603 has been researched along with Acute Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, T; Fujimi, A; Hirayama, Y; Kato, J; Kogawa, K; Kon, S; Konuma, Y; Kuroda, H; Kusakabe, T; Lu, Y; Matsunaga, T; Niitsu, Y; Nishiie, K; Sakamaki, S; Takemoto, N | 1 |
1 other study(ies) available for tak 603 and Acute Disease
Article | Year |
---|---|
Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603.
Topics: Acute Disease; Administration, Oral; Animals; Bone Marrow Transplantation; Cytokines; Drug Evaluation, Preclinical; Female; Graft vs Host Disease; Immunosuppressive Agents; Intestines; Liver; Lymphocyte Count; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Quinolines; Radiation Chimera; Skin; Spleen; Th1 Cells; Transplantation, Homologous; Triazoles | 2001 |